Today in Cis Privilege: Renewed Concerns For Females As Cloning Technology Advances

the issue of oocyte acquisition for the research and any putative therapy: compensating women for giving up their oocytes, and potentially putting their health at risk, as they have to subject themselves to injections of powerful hormones to stimulate the production of oocytes and undergo a painful procedure to have them surgically removed.

Today in Cis Privilege: 254 Poor Women Killed in India as Medical ‘Guinea Pigs’ for Cervical Cancer Studies

The death of 254 women from poor families from villages and slums in India, who were participants in US-funded clinical trials for cervical cancer, has triggered public outrage about the ethics of how clinical trials are conducted in India. The women who died were part of a control group who were kept without screening to study death rates in unscreened populations.